Terms: = Breast cancer AND KEAP1, INrf2, ENSG00000079999, 9817, Q14145, MGC9454, MGC4407, MGC20887, MGC1114, MGC10630, KLHL19, KIAA0132 AND Prognosis
10 results:
1. TMED2 Induces Cisplatin Resistance in breast cancer via Targeting the keap1-Nrf2 Pathway.
Liang C; Zhang HY; Wang YQ; Yang LA; Du YS; Luo Y; Zhang TC; Xu Y
Curr Med Sci; 2023 Oct; 43(5):1023-1032. PubMed ID: 37615927
[TBL] [Abstract] [Full Text] [Related]
2. Machine Learning Identifies Pan-cancer Landscape of Nrf2 Oxidative Stress Response Pathway-Related Genes.
Li N; Zhan X
Oxid Med Cell Longev; 2022; 2022():8450087. PubMed ID: 35242279
[TBL] [Abstract] [Full Text] [Related]
3. FAM129B, an antioxidative protein, reduces chemosensitivity by competing with Nrf2 for keap1 binding.
Cheng KC; Lin RJ; Cheng JY; Wang SH; Yu JC; Wu JC; Liang YJ; Hsu HM; Yu J; Yu AL
EBioMedicine; 2019 Jul; 45():25-38. PubMed ID: 31262713
[TBL] [Abstract] [Full Text] [Related]
4. prognosis of hormone-dependent breast cancer seems to be influenced by keap1, NRF2 and GSTM1 genetic polymorphisms.
Almeida M; Soares M; Ramalhinho AC; Moutinho JF; Breitenfeld L
Mol Biol Rep; 2019 Jun; 46(3):3213-3224. PubMed ID: 30941643
[TBL] [Abstract] [Full Text] [Related]
5. NRF2 Induction Supporting breast cancer Cell Survival Is Enabled by Oxidative Stress-Induced DPP3-keap1 Interaction.
Lu K; Alcivar AL; Ma J; Foo TK; Zywea S; Mahdi A; Huo Y; Kensler TW; Gatza ML; Xia B
Cancer Res; 2017 Jun; 77(11):2881-2892. PubMed ID: 28416489
[TBL] [Abstract] [Full Text] [Related]
6. Expression and clinical significance of Kelch-like epichlorohydrin-associated protein 1 in breast cancer.
Zhang L; Yang WP; Wu LY; Zhu X; Wei CY
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323010
[TBL] [Abstract] [Full Text] [Related]
7. RNA-binding motif protein 47 inhibits Nrf2 activity to suppress tumor growth in lung adenocarcinoma.
Sakurai T; Isogaya K; Sakai S; Morikawa M; Morishita Y; Ehata S; Miyazono K; Koinuma D
Oncogene; 2016 Sep; 35(38):5000-9. PubMed ID: 26923328
[TBL] [Abstract] [Full Text] [Related]
8. keap1 Genetic Polymorphisms Associate with breast cancer Risk and Survival Outcomes.
Hartikainen JM; Tengström M; Winqvist R; Jukkola-Vuorinen A; Pylkäs K; Kosma VM; Soini Y; Mannermaa A
Clin Cancer Res; 2015 Apr; 21(7):1591-601. PubMed ID: 25589623
[TBL] [Abstract] [Full Text] [Related]
9. Aberrant keap1 methylation in breast cancer and association with clinicopathological features.
Barbano R; Muscarella LA; Pasculli B; Valori VM; Fontana A; Coco M; la Torre A; Balsamo T; Poeta ML; Marangi GF; Maiello E; Castelvetere M; Pellegrini F; Murgo R; Fazio VM; Parrella P
Epigenetics; 2013 Jan; 8(1):105-12. PubMed ID: 23249627
[TBL] [Abstract] [Full Text] [Related]
10. Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas.
Karihtala P; Kauppila S; Soini Y; Arja-Jukkola-Vuorinen
BMC Cancer; 2011 Jun; 11():262. PubMed ID: 21693047
[TBL] [Abstract] [Full Text] [Related]
